Radiotherapy and radiosensitivity syndromes in DNA repair gene mutations.

Area of Science:

• Oncology
• Genetics
• Radiation Biology

Background:

• Ionizing radiation-induced DNA damage is the primary mechanism of radiotherapy (RT).
• Treatment outcomes and healthy tissue toxicity are influenced by DNA repair gene mutations.
• DNA repair disorders can lead to heightened sensitivity to cancer therapies.

Purpose of the Study:

• To elucidate DNA repair mechanisms and genetic syndromes impacting radiosensitivity.
• To understand how mutations in DNA repair genes contribute to carcinogenesis and RT sensitivity.
• To review inherited radiosensitivity syndromes, predominantly autosomal recessive, including ataxia telangiectasia, Nijmegen breakage syndrome, xeroderma pigmentosum, Cockayne syndrome, Bloom syndrome, and Werner syndrome.

Main Methods:

• Literature review of DNA repair mechanisms.
• Analysis of genetic syndromes associated with DNA repair gene mutations.
• Review of clinical implications for radiotherapy in patients with these syndromes.

Main Results:

• Genetic mutations in DNA repair pathways significantly affect radiosensitivity.
• Autosomal recessive inherited syndromes (e.g., Ataxia Telangiectasia, Xeroderma Pigmentosum) confer substantial radiosensitivity.
• Li-Fraumeni syndrome presents a high risk of secondary malignancies post-radiotherapy.

Conclusions:

• Radiotherapy is generally contraindicated for homozygous individuals with recessive radiosensitivity syndromes.
• Asymptomatic heterozygotes may have slightly increased risks of tumor incidence or RT intolerance, but typically do not require treatment limitation.
• Adjuvant radiotherapy is contraindicated in Li-Fraumeni syndrome due to the elevated risk of secondary cancers.